Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder caused by
deficient activity of the enzyme alpha-galactosidase. While AFD is recognized as a …

Anderson–Fabry disease (AFD) is a lysosome storage disorder resulting from an X-linked
inheritance of a mutation in the galactosidase A (GLA) gene encoding for the enzyme alpha …

Objective: Given the psychosocial and ethical burden, patients with hypertrophic
cardiomyopathy (HCMs) could benefit from the establishment of genetic probability prior to …

Fabry disease (FD) is a genetic lysosomal storage disease with frequent cardiovascular
involvement, whose presence is a major determinant of adverse clinical outcomes. As a …

As a slowly progressive form of hypertrophic cardiomyopathy (HCM), Anderson-Fabry
disease (FD) resembles the phenotype of the most common sarcomeric forms, although …

Abnormalities in impulse generation and transmission are among the first signs of cardiac
remodeling in cardiomyopathies. Accordingly, 12-lead electrocardiogram (ECG) of patients …

The standard 12-lead electrocardiogram (ECG) represents a cornerstone for the diagnosis
and evaluation of hypertrophic cardiomyopathy (HCM), the most common genetically …

Background Little is known about prevalence and predictors of myocardial infarction with
non-obstructive coronary arteries (MINOCA) in Fabry disease (FD) and hypertrophic …

Background Background: Fabry disease (FD) is an X-linked, lysosomal storage disorder
leading to severe cardiomyopathy in a significant proportion of patients. To identify ECG …

Background Cardiac amyloidosis (CA) and Fabry disease (FD) cause myocardial damage
but may also affect the valvular and subvalvular apparatus. We aimed to evaluate the …